Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 89
- Cultivation
Is Germany’s CanG Bill Set to Unleash a Wave of German Cannabis Growers?
Germany’s highly anticipated CanG bill is now finally set to have its final reading in the Bundestag this week following months of doubt and delays.
- Uncategorized
Wird das deutsche CanG-Gesetz eine Welle von deutschen Cannabisanbauern auslösen?
Nach monatelangen Zweifeln und Verzögerungen soll das mit Spannung erwartete CanG-Gesetz diese Woche endlich im Bundestag abschließend beraten werden.
- Cultivation
New York Moves Step Closer to Home Grown Cannabis
New York residents are one step closer to being able to grow their own cannabis after the state’s Cannabis Control Board (CCB) approved draft rules for home cultivation.
- Uncategorized
Nevada’s First Cannabis Consumption Lounge to Open in Las Vegas Later This Month
Las Vegas is set to see its first legal cannabis consumption lounge open after Nevada regulators issued the first of what is expected to be dozens of licences.
- Sponsored
Strategic Talent Acquisition in Europe’s Cannabis Industry: Lumino’s Visionary Approach
In the fast-paced and ever-evolving European cannabis industry, the scramble for top-tier talent is intensifying.
- Adult-Use
New York Cannabis Control Board Due to Issue Over 100 Licenses Today
New York’s embattled Cannabis Control Board (CCB) is set to significantly expand the state’s legal cannabis market today as it expects to approve 110 new licenses.
- Uncategorized
Wisconsin’s Restrictive Medical Cannabis Bill Put on Ice Until Next Session
Optimism that Wisconsin could soon roll out a medical cannabis framework has been squashed after the Assembly Speaker confirmed no hearing will take place before the Assembly adjourns next week.
- Policy & Regulation
Optimism Despite Delays: Ireland’s Journey Toward Cannabis Decriminalisation
The Irish Government has approved the establishment of an Oireachtas committee to examine the Citizens’ Assembly recommendations for the decriminalisation of drug use ‘as quickly as possible’.
- Uncategorized
DEA Deadline to Respond to Democratic Senators on Rescheduling Missed, As Efforts to Clarify Timeline Continue
US Democratic Senators’ demands for the Drug Enforcement Agency (DEA) to make public the steps it is taking to act on the recommendations from the Department of Health and Human Services (HHS) that cannabis should be rescheduled.
- Uncategorized
The Travel Agency: A Cannabis Store Celebrates First Anniversary, Generates Almost $5 Million in Tax Revenue for NY State
The Travel Agency: A Cannabis Store, the third licensed CAURD dispensary to open in New York, is celebrating the one year anniversary since selling its first cannabis products in the legal adult use market.
- Markets & Stocks
MGC Pharma to Rebrand to Argent BioPharma, OCT Explores Capital Reorganisation, & Cannabis Poland’s Stock Skyrockets
MGC Pharmaceuticals / Argent BioPharma [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand in 2024, as businesses increasingly try to diversify and distance themselves from the difficulties experienced across the cannabis sector over the last year…
- Press releases
Bedrocan Opens Its Own Cannabis Clinical Research Unit
Bedrocan, which for years has only supported external researchers financially, today announced the launching of its own Clinical Research Unit to conduct research into the effects of the cannabis products it produces on behalf of the Dutch government.











